193 related articles for article (PubMed ID: 15870144)
1. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
Uthman I; Husari A; Touma Z; Kanj SS
Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
[No Abstract] [Full Text] [Related]
2. Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept.
Maimon N; Brunton J; Chan AK; Marras TK
Thorax; 2007 Aug; 62(8):739-40. PubMed ID: 17687101
[TBL] [Abstract][Full Text] [Related]
3. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
Kekow J; Welte T; Kellner U; Pap T
Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
[No Abstract] [Full Text] [Related]
4. Macrophage activation syndrome after etanercept treatment.
Sandhu C; Chesney A; Piliotis E; Buckstein R; Koren S
J Rheumatol; 2007 Jan; 34(1):241-2. PubMed ID: 17216706
[No Abstract] [Full Text] [Related]
5. Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
Watson P; Simler N; Screaton N; Lillicrap M
Rheumatology (Oxford); 2008 Jun; 47(6):928-9. PubMed ID: 18385217
[No Abstract] [Full Text] [Related]
6. Mesenteric and splenic cat-scratch disease during etanercept therapy.
Schiffmann A; Pers YM; Lukas C; Combe B; Morel J
Rheumatology (Oxford); 2009 Nov; 48(11):1461-2. PubMed ID: 19690129
[No Abstract] [Full Text] [Related]
7. Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs.
Curtis JR; Martin C; Saag KG; Patkar NM; Kramer J; Shatin D; Allison J; Braun MM
Arthritis Rheum; 2007 Mar; 57(2):343-6. PubMed ID: 17330283
[No Abstract] [Full Text] [Related]
8. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
[No Abstract] [Full Text] [Related]
9. Pulmonary rheumatoid nodules in an etanercept-treated patient.
Hübscher O; Re R; Iotti R
Arthritis Rheum; 2003 Jul; 48(7):2077-8. PubMed ID: 12847707
[No Abstract] [Full Text] [Related]
10. Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment.
Lindsay K; Melsom R; Jacob BK; Mestry N
Rheumatology (Oxford); 2006 Aug; 45(8):1048-9. PubMed ID: 16760195
[No Abstract] [Full Text] [Related]
11. Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor.
Hall HA; Zimmermann B
Arthritis Rheum; 2006 Dec; 55(6):982-4. PubMed ID: 17139649
[No Abstract] [Full Text] [Related]
12. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
[TBL] [Abstract][Full Text] [Related]
13. Delayed multiple injection site reaction in a rheumatoid arthritis patient treated with etanercept.
Rajakulendran S; Deighton C
Rheumatology (Oxford); 2004 Dec; 43(12):1588-9. PubMed ID: 15564639
[No Abstract] [Full Text] [Related]
14. Septic arthritis due to Listeria monocytogenes in a patient receiving etanercept.
Rachapalli S; O'Daunt S
Arthritis Rheum; 2005 Mar; 52(3):987. PubMed ID: 15751076
[No Abstract] [Full Text] [Related]
15. Etanercept-induced dermatitis in a patient with rheumatoid arthritis.
Lai-Cheong J; Warren R; Bucknall R; Parslew R
J Eur Acad Dermatol Venereol; 2006 May; 20(5):614-5. PubMed ID: 16684300
[No Abstract] [Full Text] [Related]
16. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V
CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602
[TBL] [Abstract][Full Text] [Related]
17. Coarctation of the aorta in an infant exposed to etanercept in utero.
Hemmati I; Stephanie E; Shojania K
J Rheumatol; 2009 Dec; 36(12):2848. PubMed ID: 19966200
[No Abstract] [Full Text] [Related]
18. Etanercept: anti-tumor necrosis factor therapy for rheumatoid arthritis.
McGahan L
Issues Emerg Health Technol; 1999 Oct; (8):1-6. PubMed ID: 11811215
[No Abstract] [Full Text] [Related]
19. Etanercept-associated SLE with lupus nephritis.
Neradová A; Stam F; van den Berg JG; Bax WA
Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
[No Abstract] [Full Text] [Related]
20. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
Sendur OF; Turan Y; Berkit IK; Tastaban E
Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
